Camden National director granted 919 CAC shares
Page James H reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Page James H reported acquisition or exercise transactions in this Form 4 filing.
Camden National Corp director James H. Page received a grant of 919 shares of Common Stock as equity compensation. The shares were awarded under the Independent Directors' Equity Compensation Program, a component of the 2022 Equity and Incentive Plan and Amendment, and vested immediately on the grant date. After this award, Page directly holds 10,896 shares of Camden National Corp common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 919 | $0.00 | $0.00 |
Footnotes (1)
- F1. Shares granted under the Independent Directors' Equity Compensation Program, a component of the 2022 Equity and Incentive Plan and Amendment; therefore, price is N/A. These shares vested immediately on the date of the grant.
Key Figures
Key Terms
Independent Directors' Equity Compensation Program financial
2022 Equity and Incentive Plan and Amendment financial
Common Stock financial
Grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Camden National Corp (CAC) report for James H. Page?
Was the June 1, 2026 CAC insider transaction a stock purchase or a grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.